Details

Autor(en) / Beteiligte

• Peters, Verena
• Calabrese, Vittorio
• Forsberg, Elisabete
• Volk, Nadine
• Fleming, Thomas
• Baelde, Hans
• Weigand, Tim
• Thiel, Christian
• Trovato, Angela
• Scuto, Maria
• Modafferi, Sergio
• Schmitt, Claus Peter

Titel

Protective Actions of Anserine Under Diabetic Conditions

Ist Teil von

• International journal of molecular sciences, 2018-09, Vol.19 (9), p.2751

Ort / Verlag

Switzerland: MDPI AG

Erscheinungsjahr

2018

Quelle

MEDLINE

Beschreibungen/Notizen

• In rodents, carnosine treatment improves diabetic nephropathy, whereas little is known about the role and function of anserine, the methylated form of carnosine. Antioxidant activity was measured by oxygen radical absorbance capacity and oxygen stress response in human renal tubular cells (HK-2) by RT-PCR and Western-Immunoblotting. In wildtype (WT) and diabetic mice (db/db), the effect of short-term anserine treatment on blood glucose, proteinuria and vascular permeability was measured. Anserine has a higher antioxidant capacity compared to carnosine ( < 0.001). In tubular cells (HK-2) stressed with 25 mM glucose or 20⁻100 µM hydrogen peroxide, anserine but not carnosine, increased intracellular heat shock protein (Hsp70) mRNA and protein levels. In HK-2 cells stressed with glucose, co-incubation with anserine also increased hemeoxygenase (HO-1) protein and reduced total protein carbonylation, but had no effect on cellular sirtuin-1 and thioredoxin protein concentrations. Three intravenous anserine injections every 48 h in 12-week-old db/db mice, improved blood glucose by one fifth, vascular permeability by one third, and halved proteinuria (all < 0.05). Anserine is a potent antioxidant and activates the intracellular Hsp70/HO-1 defense system under oxidative and glycative stress. Short-term anserine treatment in diabetic mice improves glucose homeostasis and nephropathy.